title: Will drug companies' price-transparency efforts fall short?
authors.forename: Bryant
authors.initials: B
authors.lastname: Furlow
mesh_terms: D017046:Cost Savings; D003365:Costs and Cost Analysis; D016527:Drug Costs / Q000592:standards*; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D016134:Organizational Policy